Home > Boards > US Listed > Biotechs > BioVie Inc. (BIVI)

NASDAQ bound!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ejobkar Member Profile
 
Followed By 3
Posts 852
Boards Moderated 0
Alias Born 03/05/12
160x600 placeholder
BioVie to Participate in B. Riley Securities Liver Disease Therapeutics Day on October 29, 2020 GlobeNewswire Inc. - 10/29/2020 8:00:10 AM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/28/2020 3:48:23 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/23/2020 7:30:09 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/23/2020 7:18:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/22/2020 3:11:04 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/21/2020 7:41:28 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/21/2020 7:31:32 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 10/21/2020 6:11:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 2:08:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 2:06:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 1:50:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2020 8:11:43 AM
BioVie Announces Closing of Public Offering of Common Stock GlobeNewswire Inc. - 9/23/2020 8:00:10 AM
Highly Accomplished Executives Join BioVie’s Board of Directors GlobeNewswire Inc. - 6/16/2020 8:30:10 AM
BioVie Advances the BIV201 Clinical Program and Prefilled Syringe GlobeNewswire Inc. - 6/11/2020 8:30:10 AM
BioVie Manufactures Novel Terlipressin Prefilled Syringe GlobeNewswire Inc. - 12/9/2019 8:00:10 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/25/2019 6:01:16 AM
ejobkar   Monday, 11/25/19 07:46:06 AM
Re: None
Post # of 759 
NASDAQ bound!

On November 20, 2019, the last reported sale price for our common stock as reported on the OTCQB Marketplace was $5.00 per share, after giving effect to our recently effected 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price. Our common stock and warrants have been approved for listing on The NASDAQ Capital Market (“Nasdaq”) under the symbols “BIVI” and “BIVIW,” respectively.

https://www.sec.gov/Archives/edgar/data/1580149/000152013819000485/bivi-20191122_s1a8.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences